Business Context and Reporting Period
Company: Briacell Therapeutics Corp. (BCTX)
Filing Type: Form 8-K (Current Report)
Date of Report: November 28, 2025
Reporting Period: This filing serves as a Regulation FD disclosure regarding the financial statements of BriaPro Therapeutics Corp., a two-thirds (2/3) owned subsidiary. The subsidiary's financial data covers the period ended July 31, 2025.
Key Financial Metrics
The provided text is a cover sheet and disclosure notice for the Form 8-K. It references the existence of Consolidated Financial Statements and Management's Discussion and Analysis (MD&A) for the subsidiary but does not contain specific numerical values for the following metrics:
- Revenue
- Profit/Loss
- Cash Flow
- Margins
- Debt
- Liquidity
Investors must refer to Exhibit 99.1 (Consolidated Financial Statements) and Exhibit 99.2 (MD&A) included in the full filing to obtain these figures.
Material Changes
The filing text does not provide comparative data or describe material changes versus prior periods. It solely announces the filing of the subsidiary's financial statements with the British Columbia and Alberta Securities Commissions.
Guidance, Outlook, and Risks
Management Commentary: The filing notes that the information furnished (including the exhibits) is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings under the Securities Act or Exchange Act.
Guidance and Risks: No specific forward-looking guidance, risk factors, or contingencies are detailed in the text of this Form 8-K summary. These items would be contained within the referenced MD&A (Exhibit 99.2).
Key Facts for Investor Verification
- Verify the specific financial performance of the subsidiary, BriaPro Therapeutics Corp., by reviewing Exhibit 99.1 and Exhibit 99.2 attached to the full filing.
- Confirm the ownership structure: BriaPro Therapeutics Corp. is a two-thirds (2/3) owned subsidiary of Briacell Therapeutics Corp.
- Note the regulatory status: The subsidiary's financial statements were filed with Canadian regulators (BC and Alberta Securities Commissions) and disclosed via this US Form 8-K.
- Check the trading symbols: Common Shares (BCTX), Warrants (BCTXW), and Warrants (BCTXZ) trade on The Nasdaq Stock Market LLC.